ライフサイエンスコーパス: pyelonephritis

1 inary tract infections and 49.2% of whom had pyelonephritis).

2 iated rejection, BK nephropathy, and chronic pyelonephritis).

3 cated UTI, 38 uncomplicated cystitis, and 77 pyelonephritis).

4 ced computed tomography (CECT) in diagnosing pyelonephritis.

5 ock, bacteremia, and extensive emphysematous pyelonephritis.

6 with cystitis, and 12 (19%) had symptoms of pyelonephritis.

7 outcompeted K. pneumoniae and caused severe pyelonephritis.

8 gainst uropathogenic, E. coli-induced, acute pyelonephritis.

9 which can present clinically as cystitis or pyelonephritis.

10 tool to prevent renal scarring during acute pyelonephritis.

11 h prostatic hyperplasia presented with acute pyelonephritis.

12 system of human hosts to establish ascending pyelonephritis.

13 ignificantly associated with cystitis and/or pyelonephritis.

14 seem to independently increase the risk for pyelonephritis.

15 renal infection in a murine model of E. coli pyelonephritis.

16 sm is essential for E. coli to cause chronic pyelonephritis.

17 y play a role in the pathogenesis of chronic pyelonephritis.

18 kidneys, leading to the development of acute pyelonephritis.

19 s, and the histological diagnosis of chronic pyelonephritis.

20 es obtained in 1994-96 from women with acute pyelonephritis.

21 idney and is critical to the pathogenesis of pyelonephritis.

22 to be a superior sequence for MR imaging of pyelonephritis.

23 the blood and urine of a patient with acute pyelonephritis.

24 ntation, but there were no episodes of acute pyelonephritis.

25 H/HeJ) mice to experimental Escherichia coli pyelonephritis.

26 ux, and the diagnosis and follow-up of acute pyelonephritis.

27 ce to experimental Dr+ but not to P+ E. coli pyelonephritis.

28 9mTc-glucoheptonate (GH) in the detection of pyelonephritis.

29 aded as positive, equivocal, or negative for pyelonephritis.

30 om the blood and urine of a woman with acute pyelonephritis.

31 itis and that from patients with symptoms of pyelonephritis.

32 or from the blood or urine of patients with pyelonephritis.

33 om the blood and urine of a woman with acute pyelonephritis.

34 ropism in an experimental model of ascending pyelonephritis.

35 ng test of choice for the diagnosis of acute pyelonephritis.

36 be important for the development of chronic pyelonephritis.

37 of E. coli associated with acute gestational pyelonephritis.

38 nine piglets without experimentally induced pyelonephritis.

39 sensitive and specific for the diagnosis of pyelonephritis.

40 topathologic examination in the detection of pyelonephritis.

41 ed urinary tract infections (cUTI) including pyelonephritis.

42 ctam in the treatment of complicated UTI and pyelonephritis.

43 t C3aR is protective in experimental chronic pyelonephritis.

44 helial injury in a murine model of ascending pyelonephritis.

45 complicated urinary tract infection or acute pyelonephritis.

46 TI) is common but only rarely complicated by pyelonephritis.

47 -induced renal scarring in a murine model of pyelonephritis.

48 cal trials for the treatment of cystitis and pyelonephritis.

49 nary tract infection (cUTI), including acute pyelonephritis.

50 earance in a murine model of acute bacterial pyelonephritis.

51 omplicated lower-urinary-tract infections or pyelonephritis.

52 omplicated lower-urinary-tract infections or pyelonephritis.

53 as opposed to patients with acute bacterial pyelonephritis.

54 s associated only with early risk of UTIs or pyelonephritis.

55 al ureteral obstruction, and in experimental pyelonephritis.

56 y factor in persistence of E. coli in murine pyelonephritis.

57 ting as diskospondylitis, osteomyelitis, and pyelonephritis.

58 ond 2 days postinfection in a mouse model of pyelonephritis.

59 and 2 patients in group B were found to have pyelonephritis.

60 e bacteremia (24%), osteomyelitis (20%), and pyelonephritis (13%).

61 .8%), and urinary tract infections (UTIs) or pyelonephritis (24.5% vs. 15.3%) in the first 90 days co

62 th clinical diagnosis of acute uncomplicated pyelonephritis, 255 were included in the analysis.

63 with cystitis (30-50%), pregnancy-associated pyelonephritis (30%), and chronic diarrhea (50%).

64 inical isolates (67 from patients with acute pyelonephritis, 38 from patients with cystitis, 49 from

65 participants; OR, 0.07; 95% CI, 0.01-0.41), pyelonephritis (6 studies, 455 participants; OR, 0.19; 9

66 P = .002), fever (63% vs 38%; P = .02), and pyelonephritis (67% vs 41%; P = .02).

67 ociated with the clinical syndromes of acute pyelonephritis (79%) and cystitis (82%) than in those as

68 inical syndromes of cystitis (82%) and acute pyelonephritis (79%) than in fecal strains (19%; P < 0.0

69 a UPEC virulence factor during cystitis and pyelonephritis, a fitness factor during bacteremia, and

70 isolates from cases of pediatric cystitis or pyelonephritis, adult pyelonephritis or urosepsis, or ba

71 ], 1.14-4.33) and 56% higher risk of UTIs or pyelonephritis (aHR, 1.56; 95% CI, 1.05-2.30) in the fir

72 Women with pyelonephritis also have less bacterial eradication and

73 Furthermore, males developed more severe pyelonephritis and 100% penetrant renal abscess (a compl

74 Pyelonephritis and cUTIs have emerged as infection model

75 rences using three each of the most virulent pyelonephritis and cystitis E. coli strains in our colle

76 Genomic DNA from seven UPEC (three pyelonephritis and four cystitis) isolates and three fec

77 vention and treatment strategies to mitigate pyelonephritis and its associated complications.

78 egnancy was associated with reduced rates of pyelonephritis and low birth weights, but the available

79 apenems for the management of ESBL-producing pyelonephritis and may mitigate the risk of emergence of

80 A similar degree of pyelonephritis and mortality was confirmed at day 5 afte

81 efficacy when administered orally in murine pyelonephritis and pneumonia models.

82 may be an overlooked risk factor for chronic pyelonephritis and recurrent UTI in susceptible groups,

83 ular glomeruli have been reported in chronic pyelonephritis and renal allograft rejection; this sugge

84 highly virulent bacteria capable of causing pyelonephritis and renal injury, and to selectively targ

85 Some pyelonephritis and renal scarring may be related to vesi

86 r to renal scintigraphy for the diagnosis of pyelonephritis and renal scarring.

87 to nuclear scintigraphy for the diagnosis of pyelonephritis and renal scarring.

88 vide important information about presence of pyelonephritis and renal scars, and have high negative p

89 ot dealt with, catheter blockage can lead to pyelonephritis and septicemia.

90 ated infections to complicated UTIs (cUTIs), pyelonephritis and severe urosepsis.

91 y tract infection may predispose children to pyelonephritis and subsequent complications.

92 ce in promoting host susceptibility to acute pyelonephritis and the development of permanent renal da

93 One month later, she developed pyelonephritis and urosepsis.

94 e empiric treatment of cUTI (including acute pyelonephritis), and may offer an alternative to carbape

95 atients had complicated UTI, 42.2% had acute pyelonephritis, and 13.1% had bacteremia.

96 in ABU and fecal strains compared with acute pyelonephritis, and a Pol II antagonist suppressed the d

97 nephritis (NTN, a model for crescentic GN), pyelonephritis, and acute endotoxemic kidney injury (as

98 tial fibrosis and tubular atrophy, ascending pyelonephritis, and calcineurin inhibitor toxicity.

99 hospital-acquired pneumonia, scarlet fever, pyelonephritis, and complicated urinary tract conditions

100 of focal functional disorders, such as acute pyelonephritis, and for accurate quantitation of split r

101 at presentation identify children with acute pyelonephritis, and scans obtained six months later iden

102 with cystitis and 40 were from patients with pyelonephritis], and 97 from blood specimens) for phylog

103 ted urinary tract infection (cUTI) and acute pyelonephritis (AP) in the United States.

104 aluated the value of DNI in predicting acute pyelonephritis (APN) or vesicoureteral reflux (VUR) usin

105 Acute pyelonephritis (APN) versus acute rejection (AR) is a fr

106 ng used for the investigation of focal acute pyelonephritis (APN), especially in children with urinar

107 clinical and laboratorial diagnosis of acute pyelonephritis (APN), who underwent both DW MR and CECT,

108 cUTIs and pyelonephritis are associated with high antimicrobial re

109 e pathophysiology and treatment of cUTIs and pyelonephritis are driven more by host factors than by p

110 ling women younger than 50 years of age with pyelonephritis are hospitalized.

111 d treatment duration for acute uncomplicated pyelonephritis are unknown.

112 contributes to co-trimoxazole resistance in pyelonephritis as well as in cystitis.

113 little effect on the immune defense against pyelonephritis, as medullary DCs were less CX3CR1 depend

114 of infection and potential risk factors for pyelonephritis, ascertained through computer-assisted te

115 ta also indicate that PapX encoded by a pap (pyelonephritis- associated pilus) operon of uropathogeni

116 The pyelonephritis-associated adhesin gene papG of Escherich

117 ce of genes encoding alpha-hemolysin (100%), pyelonephritis-associated pili (100%), and cytotoxic nec

118 udied included the pap operon, which encodes pyelonephritis-associated pili (P pili), the daa operon,

119 imbriae is repressed by PapB, a regulator of pyelonephritis-associated pili (P-pili).

120 Pyelonephritis-associated pili (pap) allow uropathogenic

121 Pyelonephritis-associated pili (Pap) expression in uropa

122 The expression of pyelonephritis-associated pili (Pap) in uropathogenic Es

123 The pyelonephritis-associated pili (pap) operon in Escherich

124 y cross-talk between multiple phase-variable pyelonephritis-associated pili (pap) operons in Escheric

125 In the pyelonephritis-associated pili (pap) system, global regu

126 emselves to the epithelial cells through the pyelonephritis-associated pili (pap).

127 structure at 3.15-A resolution of the usher pyelonephritis-associated pili C (PapC) translocation do

128 rs, including the Pap operon which specifies pyelonephritis-associated pili.

129 quences within the regulatory regions of the pyelonephritis-associated pilus (pap) operon and the glu

130 Expression of the pyelonephritis-associated pilus (pap) operon in Escheric

131 on shares features with the Escherichia coli pyelonephritis-associated pilus (pap) operon, which is u

132 tis-associated strains appear to differ from pyelonephritis-associated strains in elaboration of some

133 logy to those of the well-characterized Pap (pyelonephritis-associated) pili and related systems, alt

134 wenty-six kidneys (54 zones) had evidence of pyelonephritis at both MR imaging and scintigraphy.

135 inical isolates from patients with cystitis, pyelonephritis, bacteremia, or meningitis, including arc

136 In acute pyelonephritis, bacterial resistance to co-trimoxazole p

137 iffusion-weighted (DW) imaging in diagnosing pyelonephritis based on renal cortical and medullary app

138 Acidosis is associated with E. coli induced pyelonephritis but whether bacterial cell wall constitue

139 to Grade 3 cortical lesions in patients with pyelonephritis, but it is less effective in detecting Gr

140 They respond to both cystitis and pyelonephritis by delivering bacteriostatic chemical age

141 n inducing innate immunity against bacterial pyelonephritis by recruiting neutrophils through rapid c

142 Allograft pyelonephritis can be a diagnostic and therapeutic chall

143 These findings suggest that pyelonephritis can be treated by reducing mitochondrial

144 Repeated or severe cases of pyelonephritis can cause renal scarring that subsequentl

145 e serious infections, characterized as acute pyelonephritis, can also develop.

146 the treatment of complicated UTIs and acute pyelonephritis caused by Enterobacteriaceae, including m

147 m (TZP) for the management of non-bacteremic pyelonephritis caused by ESBL-producing organisms.

148 am (TZP) for the management of nonbacteremic pyelonephritis caused by extended-spectrum beta-lactamas

149 Among patients with complicated UTI or acute pyelonephritis caused by gram-negative pathogens, cefepi

150 ed urinary tract infections (cUTI) including pyelonephritis caused by susceptible gram-negative bacte

151 of complicated urinary tract infections and pyelonephritis caused by susceptible organisms.

152 The pathogenesis of pyelonephritis caused by uropathogenic Escherichia coli

153 Acute pyelonephritis causes significant morbidity, tends to re

154 a competition assay, we demonstrated that a pyelonephritis clinical isolate had a growth advantage o

155 rrent cystitis, asymptomatic bacteriuria, or pyelonephritis could progress through the IBC cascade in

156 e more-virulent strains (those causing acute pyelonephritis) demonstrated a resistance, in aerated br

157 Controls were 546 similar-age women with no pyelonephritis diagnosis in the previous 5 years who wer

158 te, the cellular mechanisms underlying acute pyelonephritis-driven renal scarring remain unknown.

159 e of ampicillin resistance among gestational pyelonephritis E. coli and the association with the dra

160 P. mirabilis bacteriuria may lead to acute pyelonephritis, fever, and bacteremia.

161 seen in some other conditions, such as acute pyelonephritis; for this reason, one must be careful dur

162 herichia coli strains that cause cystitis or pyelonephritis from fecal E. coli remain incompletely de

163 ts with noncalculous disease, two with acute pyelonephritis had perinephric edema at CT.

164 Pyelonephritis has a clear seasonal pattern and high rat

165 the mechanisms through which E. coli induces pyelonephritis has accumulated.

166 Recently, an experimental model of chronic pyelonephritis has been developed with E. coli bearing D

167 ic reflux (VUR) in the pathogenesis of acute pyelonephritis has been downgraded with the recognition

168 Histopathologic examination revealed pyelonephritis in 102 zones in 38 kidneys.

169 The overall average annual incidence rate of pyelonephritis in 1997-1999 was 35.7 per 10,000 populati

170 Histopathology revealed pyelonephritis in 24 of 32 kidneys (58 of 96 zones).

171 o colonize the urinary tract and cause acute pyelonephritis in an experimental model of ascending uri

172 ology results for the presence or absence of pyelonephritis in each zone.

173 m that enables the bacteria to cause chronic pyelonephritis in experimental mice.

174 studied a model of Escherichia coli-induced pyelonephritis in mice deficient in complement component

175 mediator cAMP significantly attenuated acute pyelonephritis in mice induced by UPEC.

176 neficial for controlling UPEC-mediated acute pyelonephritis in mice.

177 ake was studied in unilateral reflux-related pyelonephritis in pigs.

178 There is adequate evidence that pyelonephritis in pregnancy is associated with negative

179 quently expressed in strains associated with pyelonephritis in pregnant females.

180 atic bacteriuria can reduce the incidence of pyelonephritis in pregnant persons.

181 ring Dr-adhesins (Dr+ E. coli) cause chronic pyelonephritis in pregnant women and animal models.

182 50% of cystitis cases in children and 30% of pyelonephritis in pregnant women.

183 e authors describe the epidemiology of acute pyelonephritis in South Korea by using nationwide heath

184 The incidence of hospitalization for pyelonephritis in South Korea is similar to that in the

185 hort studies (n = 5289) found fewer cases of pyelonephritis in the cohorts of screened pregnant women

186 Sensitivity and specificity for detecting pyelonephritis in the kidneys were 92.1% and 93.8% for S

187 Sensitivity and specificity for detecting pyelonephritis in the zones were 94.1% and 95.4% for SPE

188 specific test for detection of experimental pyelonephritis in this piglet model.

189 ic for cultured renal cells and causes acute pyelonephritis in transurethrally infected CBA mice, con

190 outpatient treatment of acute uncomplicated pyelonephritis in women, a 7-day ciprofloxacin regimen w

191 ary tract infections (UTIs), including acute pyelonephritis, in a 1:1 ratio to receive intravenous pl

192 inary tract infection (UTI), including acute pyelonephritis, in a 2:1 ratio to receive intravenous ce

193 plicated urinary tract infections, including pyelonephritis, in adults.

194 aimed at ameliorating OMCDi dysfunction and pyelonephritis-induced acidosis.

195 bsorption, providing a mechanism for E. coli pyelonephritis-induced acidosis.

196 uated for virulence in a murine hematogenous pyelonephritis infection model.

197 Cystitis and acute pyelonephritis, infection of the bladder and kidney, res

198 Acute pyelonephritis is a potentially life-threatening infecti

199 Among pregnant persons, pyelonephritis is associated with perinatal complication

200 ric oxide to host resistance to experimental pyelonephritis is not well understood.

201 mune defences or antibiotic therapy to cause pyelonephritis is paramount to the development of new pr

202 sitivity of SPECT for the detection of acute pyelonephritis is slightly better than pinhole DMSA scan

203 g community-acquired UTIs, both cystitis and pyelonephritis, is increasing.

204 ogroup O6 closely resembled archetypal human pyelonephritis isolate 536 (O6:K15:H31), according to pa

205 ates and (clonally related) archetypal human pyelonephritis isolate 536 were found to share a novel a

206 Recombinant Iha from E. coli pyelonephritis isolate CFT073 conferred upon nonadherent

207 Pyelonephritis isolate E. coli CFT073 carries 12 fimbria

208 ent incidence of ampicillin resistance among pyelonephritis isolates (46%) was significantly higher t

209 ible elements in the ON orientation than did pyelonephritis isolates (85 and 34%, respectively, at 24

210 og, and cat isolates; two included reference pyelonephritis isolates CFT073 (O6:K2:H1) and 536 (O6:K1

211 Compared with fecal and cystitis isolates, pyelonephritis isolates exhibited a greater prevalence o

212 found that internalization of both fecal and pyelonephritis isolates is blocked by tyrosine kinase in

213 n assay to assess the ability of gestational pyelonephritis isolates of Escherichia coli to invade He

214 ystitis and pyelonephritis isolates, 2 among pyelonephritis isolates only, and 3 among cystitis isola

215 12 (7%) of the pyelonephritis isolates were in clonal group A (CGA; res

216 robes were more prevalent among cystitis and pyelonephritis isolates, 2 among pyelonephritis isolates

217 In general, cystitis isolates, unlike pyelonephritis isolates, were more likely to maintain th

218 demonstrate that in the early stage of acute pyelonephritis kidney tubules participate actively in th

219 o three categories; febrile upper UTI (acute pyelonephritis), lower UTI (cystitis), and asymptomatic

220 n, sepsis, pneumonia, acute gastroenteritis, pyelonephritis, meningitis or encephalitis, cellulitis o

221 uation in growth when analyzed in the murine pyelonephritis model.

222 s from women in the United States with acute pyelonephritis (n = 170), cystitis (n = 83), or no infec

223 = 27), whereas pic was present in 31% of the pyelonephritis (n = 67) and 7% of the fecal strains.

224 wel obstruction (n=2), cholelithiasis (n=2), pyelonephritis (n=2), diaphragmatic hernia (n=1), cecal

225 Escherichia coli urine isolates showed that pyelonephritis (n=23) and prostatitis (n=17) isolates ex

226 on besides signs consistent with subclinical pyelonephritis (n=3).

227 Although most cases of acute pyelonephritis occur in otherwise healthy women, data on

228 10% of pregnant women and is associated with pyelonephritis, one of the most common nonobstetric reas

229 bacteria are isolated from individuals with pyelonephritis or from healthy volunteers.

230 enitourinary coccidioidomycosis manifests as pyelonephritis or pelvic abscesses.

231 obscure underlying uropathogens, leading to pyelonephritis or potential neonatal infection if untrea

232 ic GN, acute tubular necrosis, and infective pyelonephritis or sepsis.

233 , P = 0.008), whereas episodes of transplant pyelonephritis or urosepsis were not more frequent (3 vs

234 pediatric cystitis or pyelonephritis, adult pyelonephritis or urosepsis, or bacteremia (range, 38 to

235 ted with severe UTI, i.e., kidney infection (pyelonephritis) or urinary-source bacteremia, from non-i

236 rsions exposed grafts to more frequent acute pyelonephritis (P = 0.02).

237 re frequently in isolates from patients with pyelonephritis (P=3.6x10-9), in periurethral isolates (P

238 ography had 0% sensitivity for appendicitis, pyelonephritis, pancreatitis, and diverticulitis.

239 exposed grafts to more frequent acute graft pyelonephritis, patient and graft survival rates in LUTM

240 rains from different clinical sources (acute pyelonephritis patients, cystitis patients, and fecal co

241 o-occlusive crisis, asthma crisis, and acute pyelonephritis per 1000 children with SCD over the same

242 tive and reliable for the detection of acute pyelonephritis; power Doppler US is significantly less a

243 coli isolates from patients with cystitis or pyelonephritis produce the pore-forming cytotoxin hemoly

244 Induction of unilateral pyelonephritis produced a small reduction in diseased ki

245 es, imu1-3, are associated with strains from pyelonephritis, prostatitis, and bacteremia of urinary t

246 past 30 years), there were reduced rates of pyelonephritis (range, 0%-16.5% for the intervention gro

247 s in adults hospitalized with ESBL-producing pyelonephritis receiving TZP versus carbapenems using an

248 were classified as positive or negative for pyelonephritis regardless of the severity and number of

249 cteria interactions, diagnostic evaluations, pyelonephritis, renal cortical scarring, and long term f

250 In contrast, all benign lesions, including pyelonephritis, renal cysts, adenomas, oncocytomas, and

251 th abundant bacterial growth, pneumonia, and pyelonephritis, requiring euthanasia.

252 Experimental neutropenia during acute pyelonephritis resulted in a compensatory increase in th

253 ultivariable models, factors associated with pyelonephritis risk were frequency of sexual intercourse

254 history of UTI are associated with increased pyelonephritis risk.

255 with severe human infections including acute pyelonephritis, sepsis, and neonatal meningitis.

256 tizing granulomas, inflammatory changes, and pyelonephritis, some of which were fungal.

257 ile receiving sirolimus, including diarrhea, pyelonephritis, stomatitis, and respiratory infections.

258 ted repeat of the invertible element of UPEC pyelonephritis strain CFT073 that locked the invertible

259 Outer membranes were isolated from pyelonephritis strain E. coli CFT073 cultured under cond

260 lates, being significantly more prevalent in pyelonephritis strains (53% of isolates) than in asympto

261 more critical for cystitis strains than for pyelonephritis strains in the early stages of an infecti

262 e evidence that cystitis strains differ from pyelonephritis strains in this model, that this model is

263 strains, and that it would be unwise to use pyelonephritis strains to study putative virulence facto

264 ns colonize the bladder more rapidly than do pyelonephritis strains, while the rates of kidney coloni

265 eliminated from the mouse urinary tract than pyelonephritis strains.

266 sociated with the clinical syndrome of acute pyelonephritis than by faecal strains (P = 0.029).

267 In children, the acute pyelonephritis that can result from urinary tract infect

268 ization for primary UTI, sepsis with UTI, or pyelonephritis; the secondary outcome was outpatient UTI

269 uropathogenic Escherichia coli-induced acute pyelonephritis to determine the contribution of neutroph

270 d pinhole imaging for the detection of acute pyelonephritis using histology as the standard of refere

271 were analyzed in a mouse model of ascending pyelonephritis, using E. coli with (P+) and without (P-)

272 < or = 0.015) predictors of cystitis and/or pyelonephritis (versus fecal) included afa/dra (Dr-bindi

273 te tubular necrosis, urinary tract infection/pyelonephritis, viral nephritis, and interstitial nephri

274 greement between readers for the presence of pyelonephritis was 0.85 and 0.57 for MR imaging and scin

275 Here, we show that pyelonephritis was associated with oxidative stress and

276 In unilaterally denervated mice, pyelonephritis was attenuated and intrarenal neutrophil

277 Acute pyelonephritis was diagnosed in 61 percent of the childr

278 dy of 80 juvenile diabetic patients, chronic pyelonephritis was found histologically in seven (9%) of

279 Pyelonephritis was induced by injecting 100 million HlyA

280 mmune response, a unilateral acute ascending pyelonephritis was induced in rats by intrabladder inocu

281 lated from the blood of a patient with acute pyelonephritis, was most cytotoxic and most virulent in

282 biotic therapy for ASB, cystitis, CA-UTI and pyelonephritis were 10.0 (4.5), 11.4 (4.7), 12.0 (6.1),

283 urring with induction and after treatment of pyelonephritis were correlated with the DMSA images and

284 i isolates taken from 78 pregnant women with pyelonephritis were evaluated.

285 More patients with pyelonephritis were given appropriate empirical antibiot

286 The results of MR imaging for pyelonephritis were not equivalent to the results of sci

287 ed or microbiologically confirmed cUTI/acute pyelonephritis were randomized 1:1 to ceftazidime-avibac

288 complicated lower-urinary-tract infection or pyelonephritis were randomly assigned in a 1:1 ratio to

289 rolled, 800 (73.9%), of whom 656 (82.0%) had pyelonephritis, were included in the microbiological MIT

290 ced kidney pathologies, such as cystitis and pyelonephritis, which are associated with an inflammator

291 eral reflux (VUR) is a risk factor for acute pyelonephritis, which can result in renal scarring (refl

292 infected with Escherichia coli develop acute pyelonephritis, while other patients with bacteriuria ex

293 Case-patients (n = 242) were women with pyelonephritis who were identified from computerized dat

294 s of adults hospitalized with ESBL-producing pyelonephritis who were receiving TZP versus carbapenems

295 h clinical and laboratory diagnosis of acute pyelonephritis, who were referred for radiological imagi

296 The father developed severe, recurrent pyelonephritis with multiple small abscesses; the daught

297 nts (20% vs. 25%) with recurrent cystitis or pyelonephritis with the same ESBL-producing organism wit

298 ents (20% vs 25%) with recurrent cystitis or pyelonephritis with the same ESBL-producing organism wit

299 eatment of complicated UTIs, including acute pyelonephritis, with a noninferiority margin of 15 perce

300 tment of complicated UTI that included acute pyelonephritis, with a safety profile similar to that of